NCT00643097 arm group f30926ce7a02e400074d38c75ec40ca1 [clinicaltrials_resource:NCT00643097/arm-group/f30926ce7a02e400074d38c75ec40ca1]
NCT00643097 arm group f30926ce7a02e400074d38c75ec40ca1 [clinicaltrials_resource:NCT00643097/arm-group/f30926ce7a02e400074d38c75ec40ca1]
Bio2RDF identifier
NCT00643097/arm-group/f30926ce7a02e400074d38c75ec40ca1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 0926ce7a02e400074d38c75ec40ca1
description [clinicaltrials_vocabulary:description]
Patients first receive 3 initi ...... irst 5 days of a 28 day cycle.
identifier
clinicaltrials_resource:NCT00643097/arm-group/f30926ce7a02e400074d38c75ec40ca1
title
NCT00643097 arm group f30926ce7a02e400074d38c75ec40ca1
@en
type
label
NCT00643097 arm group f30926ce ...... 926ce7a02e400074d38c75ec40ca1]
@en